Survey of Hospitalizations due to Leishmaniasis in Adults during the Pre and Post COVID-19 Pandemic Periods in Feira de Santana, Brazil

Beatriz Carneiro de Carvalho *

Unidade de Ensino Superior de Feira de Santana (UNEF)-Bahia, Brazil.

Lívia Gabrielly Cruz da Silva

Unidade de Ensino Superior de Feira de Santana (UNEF)-Bahia, Brazil.

João Ronaldo Tavares de vasconcellos Neto

Unidade de Ensino Superior de Feira de Santana (UNEF)-Bahia, Brazil.

*Author to whom correspondence should be addressed.


Aims: Neglected tropical diseases, such as Visceral Leishmaniasis, affect over 1 billion people in tropical and subtropical regions, with Leishmaniasis being endemic in various parts of the world and causing up to 1 million new cases annually. It is crucial to investigate the decline in hospitalization cases in Feira de Santana and its possible linkage with the COVID-19 pandemic and local socioeconomic factors.

Study Design:  An exploratory-descriptive bibliographic study with a qualitative approach.

Place and Duration of Study: Department of Health, Higher Education Unit of Feira de Santana, Feira de Santana (Bahia), during the first semester of 2024.

Methodology: The bibliographic survey was conducted through searches of scientific productions on the proposed theme, from 2018 to 2024. Searches were performed using keywords in Portuguese and English with the Boolean operator "AND". In addition to literature review, the collection of secondary data was conducted by the Department of Health Informatics of the Unified Health System (DATASUS).

Results: The complex interaction among socioeconomic, environmental, and public health factors, exacerbated by the COVID-19 pandemic, impacts the dissemination, underreporting, and control of leishmaniasis, highlighting the urgent need for integrated approaches and strengthening of health systems to effectively address this neglected disease.

Conclusion: Therefore, it is concluded that the main causes may include reductions or delays in notifications, which can lead to difficulties in differentiating diseases with similar clinical presentations and even coinfections.

Keywords: Leishmaniose, pandemia, hospitalização

How to Cite

Carvalho , Beatriz Carneiro de, Lívia Gabrielly Cruz da Silva, and João Ronaldo Tavares de vasconcellos Neto. 2024. “Survey of Hospitalizations Due to Leishmaniasis in Adults During the Pre and Post COVID-19 Pandemic Periods in Feira De Santana, Brazil”. Asian Journal of Medicine and Health 22 (7):70-78.


Download data is not yet available.


Shams M. et al. Real‐time impact of COVID‐19 pandemic on cutaneous leishmaniasis case finding and strategic planning, preventive interventions, control and epidemiology in a region with a high burden of cutaneous leishmaniasis and COVID‐19: A cross‐sectional descriptive study based on registry data in Ilam‐Iran. Health science reports. 2023;6(8).

Vuitika L. et al. Vaccines against Emerging and Neglected Infectious Diseases: An Overview. Vaccines. 2022;10(9):1385.

Rijal S. et al. Eliminating visceral leishmaniasis in South Asia: the road ahead. BMJ. 2019;364.

Santos GC. DE A, Mariano SMB, Silva JBNF. COVID-19 and the incidence of neglected tropical diseases: reflections from pandemic times. ABCS Health Sciences. 2021;46(1):e021102.

Bahia. Secretaria de Saúde. Boletim Epidemiológico COVID-19 Bahia nº 13; 2024.Available:

Gil Antonio Carlos. Como Elaborar Projetos De Pesquisa . 7. ed. [s.l.]: Atlas, 2022.

Gonçalves Hortência de Abreu. Manual de metodologia da pesquisa científica. 3. ed. São Paulo: Avercamp; 2023.

Minayo, Maria Cecília de Souza. Pesquisa Social: teoria, método e criatividade. 26. ed. São Paulo: Editora Vozes; 2007.

Ministério Saúde. Visceral Leishmaniasis Surveillance and Control Manual - 1st ed. Series A. Brasília- DF, 2006. MS Publisher; 2024.Available:

Silveira JRS. et al. Impact of the COVID-19 Pandemic Surveillance of Visceral Leishmaniasis in Brazil: An Ecological Study. Infectious Disease Reports. 2024;16(1):116–127.

Uwishema O. et al. Leishmaniasis control in the light of the COVID-19 pandemic in Africa. Annals of Medicine and Surgery. 2022;80(1):104263.

Numan M. et al. Evaluation of Household Preparedness and Risk Factors for Cutaneous Leishmaniasis (CL) Using the Community Assessment for Public Health Emergency Response (CASPER) Method in Pakistan. International Journal of Environmental Research and Public Health. 2022;19(9):5068.

Longoni SS. et al. Monoclonal Antibodies for Protozoan Infections: A Future Reality or a Utopic Idea? Frontiers in Medicine. 2021;8(1).

Tilli M. et al. Neglected tropical diseases in non-endemic countries in the era of COVID-19 pandemic: the great forgotten. Journal of Travel Medicine. 2020;1(1).

Oliveira R. DE S. et al. Impact of COVID-19 on the registration of cutaneous leishmaniasis cases in Maranhão, Brazil. Journal of Epidemiology and Infection Control. 2023;13(3).

Saúde OPA. DA. Leishmaniasis: Epidemiological Report of the Americas, No. 12. 2023;1(1).

Shomik Maruf et al. Assessment of treatment outcomes of visceral leishmaniasis (VL) treated cases and impact of COVID-19 on VL Management and Control Services in Bangladesh. Journal of Infection and Public Health. 2023;16(11):1716–1721.

Dias NLC, Faccini-Martínez ÁA, Oliveira SVDE. Analysis of hospitalizations and mortality due to febrile, infectious and parasitic diseases during the COVID-19 pandemic in Brazil. 2020;1(1).

Saúde OPA. DA. Leishmaniasis: Epidemiological report from the Americas. No 11. 2022;1(1).

Saúde OPA. DA. Leishmaniasis: Epidemiological Report of the Americas, No. 10. 2021;1(1).

Cardona‐Ospina JA, Arteaga‐Livias K, Villamil‐Gómez WE, Pérez‐Díaz CE, Katterine Bonilla‐Aldana D, Mondragon‐Cardona Á, Solarte‐Portilla M MARTINEZ E Millan‐Oñate J, López‐Medina E, López P, Navarro J, Perez‐Garcia L, Mogollon‐Rodriguez E, Rodríguez‐Morales AJ, Paniz‐Mondolfi A. Dengue and COVID‐19, overlapping epidemics? An analysis from Colombia. Journal of Medical Virology. 2020; 93(1):522–527.

Amimo F, Lambert B, Magit A. What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control?. Trop Med Health. 2020;48(32).

Borlase A. et al. Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study. The Lancet Global Health. 2022;10(11):1600–e1611.

Fatemeh Nemati Zargaran et al. Co-infection of COVID-19 and parasitic diseases: A systematic review. Elsevier. 2023;21(1):e00299–e00299.

MAYILSAMY, M. et al. Impact of COVID 19 Lockdown during 2020 on the occurrence of Vector-Borne Diseases in India. Journal of Vector Borne Diseases; 2022.

LI, H.-Y. et al. Advances in detection of infectious agents by aptamer-based technologies. Emerging Microbes & Infections. 2020;9(1):1671–1681.

Le Rutte EA. et al. Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2021;115(3):229–235.

Topno RK, Dikhit MR, Kumar M, Madhukar, Agrawal K, Ali V, Sahoo GC, Kumar R, Sinha S, Kumar R, Bhawana Pandey K, Das VNR, Das P. Post Kala-Azar dermal leishmaniasis following treatment with 10 mg/kg of single dose ambisome for visceral leishmaniasis in Bihar, India. Int. J. Trop. Dis. Health. [Internet]. 2020 Dec. 11 [cited 2024 May 21];41(19):28-33.Available:

Sajad P, Rather S, Hassan I, Qureshi W. primary lip leishmaniasis-report of 4 cases from a non-endemic region of kashmir valley of north india and review of literature. J. Adv. Med. Med. Res. [Internet]. 2017 Oct. 4 [cited 2024 May 21];24(1):1-5.Available:

Steverding D. The history of leishmaniasis. Parasites & vectors. 2017;10:1-0.